TRIM56 and central nervous system cancer: Interestingly, we observed a broader and more jagged tumor edge in the TRIM56-OE xenograft glioma model than in TRIM56-NC model (Fig. 4H, I), indicating that TRIM56 overexpression enhanced the invasive potential of glioma cells in vivo.